Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated patients with type 2 diabetes. - Ratner,R.; Want,L.L.; Fineman,M.S.; Velte,M.J.; Ruggles,J.A.; Gottlieb,A.; Weyer,C.; Kolterman,O.G. (Diabetes Technol Ther, 2002)